Kyowa Kirin Presses On With Parkinson's Prospect In US As Successor Readied

 
• By Ian Haydock

Some 12 years after first NDA submission, Kyowa Hakko Kirin tries again to secure US approval for troubled Parkinson's drug, but some analysts remain unsure of commercial potential and the company itself is progressing a successor.

Parkinson's
Kyowa Kirin Progresses Parkinson's Prospects • Source: Shutterstock

More from Strategy

More from Business